UA92145C2 - Purified lh - Google Patents

Purified lh Download PDF

Info

Publication number
UA92145C2
UA92145C2 UAA200612399A UAA200612399A UA92145C2 UA 92145 C2 UA92145 C2 UA 92145C2 UA A200612399 A UAA200612399 A UA A200612399A UA A200612399 A UAA200612399 A UA A200612399A UA 92145 C2 UA92145 C2 UA 92145C2
Authority
UA
Ukraine
Prior art keywords
solution
stage
column
preferred
propanol
Prior art date
Application number
UAA200612399A
Other languages
English (en)
Ukrainian (uk)
Inventor
Джанфранко Парадизи
Мара Росси
Лаура Скаглия
Original Assignee
Мерк Сероно С.А.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Мерк Сероно С.А. filed Critical Мерк Сероно С.А.
Publication of UA92145C2 publication Critical patent/UA92145C2/uk

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/36—Extraction; Separation; Purification by a combination of two or more processes of different types
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/34—Gestagens
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/59—Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g.hCG [human chorionic gonadotropin]; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Endocrinology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Reproductive Health (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Diabetes (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Dermatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pregnancy & Childbirth (AREA)
  • Gynecology & Obstetrics (AREA)
  • Analytical Chemistry (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Treatment Of Liquids With Adsorbents In General (AREA)
  • Semiconductor Lasers (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
UAA200612399A 2000-02-22 2001-01-22 Purified lh UA92145C2 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP00103692 2000-02-22

Publications (1)

Publication Number Publication Date
UA92145C2 true UA92145C2 (en) 2010-10-11

Family

ID=8167926

Family Applications (2)

Application Number Title Priority Date Filing Date
UAA200612399A UA92145C2 (en) 2000-02-22 2001-01-22 Purified lh
UA2002086889A UA78676C2 (en) 2000-02-22 2001-01-22 Purified lh

Family Applications After (1)

Application Number Title Priority Date Filing Date
UA2002086889A UA78676C2 (en) 2000-02-22 2001-01-22 Purified lh

Country Status (30)

Country Link
US (2) US7053054B2 (cg-RX-API-DMAC7.html)
EP (2) EP1261622B1 (cg-RX-API-DMAC7.html)
JP (1) JP4959898B2 (cg-RX-API-DMAC7.html)
KR (1) KR100808149B1 (cg-RX-API-DMAC7.html)
CN (1) CN100480258C (cg-RX-API-DMAC7.html)
AT (1) ATE356138T1 (cg-RX-API-DMAC7.html)
AU (1) AU780377B2 (cg-RX-API-DMAC7.html)
BG (1) BG65761B1 (cg-RX-API-DMAC7.html)
BR (2) BR122012018280B8 (cg-RX-API-DMAC7.html)
CA (1) CA2399100C (cg-RX-API-DMAC7.html)
CY (1) CY1108056T1 (cg-RX-API-DMAC7.html)
CZ (1) CZ303274B6 (cg-RX-API-DMAC7.html)
DE (1) DE60127100T2 (cg-RX-API-DMAC7.html)
DK (1) DK1261622T3 (cg-RX-API-DMAC7.html)
EA (1) EA004385B1 (cg-RX-API-DMAC7.html)
EE (1) EE04932B1 (cg-RX-API-DMAC7.html)
ES (1) ES2278722T3 (cg-RX-API-DMAC7.html)
HR (1) HRP20020651B1 (cg-RX-API-DMAC7.html)
HU (1) HU227007B1 (cg-RX-API-DMAC7.html)
IL (2) IL151309A0 (cg-RX-API-DMAC7.html)
MX (1) MXPA02007867A (cg-RX-API-DMAC7.html)
NO (1) NO328693B1 (cg-RX-API-DMAC7.html)
PL (1) PL207728B1 (cg-RX-API-DMAC7.html)
PT (1) PT1261622E (cg-RX-API-DMAC7.html)
RS (1) RS50416B (cg-RX-API-DMAC7.html)
SI (1) SI1261622T1 (cg-RX-API-DMAC7.html)
SK (1) SK287041B6 (cg-RX-API-DMAC7.html)
UA (2) UA92145C2 (cg-RX-API-DMAC7.html)
WO (1) WO2001062774A2 (cg-RX-API-DMAC7.html)
ZA (1) ZA200206108B (cg-RX-API-DMAC7.html)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HRP20020651B1 (en) * 2000-02-22 2011-01-31 Laboratoires Serono Sa Purified lh
DE10235168A1 (de) * 2002-08-01 2004-02-12 Aventis Pharma Deutschland Gmbh Verfahren zur Reinigung von Preproinsulin
DE602004030546D1 (de) * 2003-03-04 2011-01-27 Aspenbio Pharma Inc LH zur Verwendung der Erhaltung einer oder mehreren Schwangerschaften durch Induktion der Bildung des sekundären Gelbkörpers.
CN1283792C (zh) * 2003-11-14 2006-11-08 余伟明 生物大分子组分相分离法
ATE446314T1 (de) * 2003-12-22 2009-11-15 Ares Trading Sa Methode zur reinigung von fsh
ATE469912T1 (de) * 2004-10-04 2010-06-15 Novetide Ltd Gegenionenaustauschverfahren für peptide
EP1809663B1 (en) * 2004-11-09 2008-09-17 Ares Trading S.A. Method for purifying fsh
US20080219952A1 (en) * 2005-08-26 2008-09-11 Ares Trading S.A. Process For the Preparation of Glycosylated Interferon Beta
JP5199112B2 (ja) * 2005-12-09 2013-05-15 アレス トレーディング ソシエテ アノニム Fsh又はfsh変異体を精製するための方法
EP2203465A1 (en) * 2007-10-22 2010-07-07 Merck Serono S.A. Method for purifying an fc-containing protein
CA2702448A1 (en) * 2007-10-22 2009-04-30 Merck Serono S.A. Method for purifying fc-fusion proteins
CN101928342B (zh) * 2009-06-18 2013-05-08 上海天伟生物制药有限公司 一种高纯度绝经期促性腺素及其制备方法和用途
WO2015168622A1 (en) * 2014-05-01 2015-11-05 Virginia Tech Intellectual Properties, Inc. Keratin nanomaterials and methods of production
CN104569441B (zh) * 2015-01-19 2016-02-03 成都大熊猫繁育研究基地 大熊猫尿液促黄体素的酶联检测方法及其应用
CA3140267A1 (en) 2019-05-16 2020-11-19 Ceva Sante Animale Compositions and methods for increasing reproduction performance in non-human mammals using recombinant luteinizing hormone

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1990002757A1 (en) * 1988-09-02 1990-03-22 Integrated Genetics, Inc. Heteropolymeric protein
DE122010000006I2 (de) * 1989-02-21 2012-06-21 Univ Washington Modifizierte formen von fortpflanzungshormonen.
US5087615A (en) * 1989-03-17 1992-02-11 Applied Research Systems Ars Holding N.V. Novel method of ovulation induction in humans
IT1250075B (it) * 1991-12-18 1995-03-30 Serono Cesare Ist Ricerca Composizioni farmaceutiche contenenti gonadotropine.
IT1287138B1 (it) * 1996-11-07 1998-08-04 Ibsa Inst Biochimique Sa Procedimento per la separazione e purificazione di fsh e lh
TW518235B (en) * 1997-01-15 2003-01-21 Akzo Nobel Nv A gonadotropin-containing pharmaceutical composition with improved stability on prolong storage
AU747179B2 (en) * 1997-06-25 2002-05-09 Merck Serono Sa Disulfide cross-linked glycoprotein hormone analogs, their preparation and use
HRP20020651B1 (en) * 2000-02-22 2011-01-31 Laboratoires Serono Sa Purified lh

Also Published As

Publication number Publication date
SI1261622T1 (sl) 2007-06-30
HUP0301814A3 (en) 2004-10-28
ZA200206108B (en) 2003-07-31
NO20023963L (no) 2002-08-20
YU60302A (sh) 2005-09-19
AU780377B2 (en) 2005-03-17
HRP20020651B1 (en) 2011-01-31
EP1777231A2 (en) 2007-04-25
JP4959898B2 (ja) 2012-06-27
HU227007B1 (en) 2010-04-28
EP1777231A3 (en) 2007-11-07
ES2278722T3 (es) 2007-08-16
KR100808149B1 (ko) 2008-02-29
WO2001062774A3 (en) 2002-03-14
BG65761B1 (bg) 2009-10-30
PT1261622E (pt) 2007-04-30
AU3543601A (en) 2001-09-03
HUP0301814A2 (hu) 2003-08-28
KR20030001358A (ko) 2003-01-06
EP1261622A2 (en) 2002-12-04
CY1108056T1 (el) 2013-09-04
BRPI0108553B8 (pt) 2021-05-25
EA004385B1 (ru) 2004-04-29
EE200200464A (et) 2003-12-15
HRP20020651A2 (en) 2004-12-31
DE60127100D1 (de) 2007-04-19
MXPA02007867A (es) 2003-02-10
SK287041B6 (sk) 2009-10-07
SK12052002A3 (sk) 2002-12-03
HK1052014A1 (zh) 2003-08-29
US20030186893A1 (en) 2003-10-02
IL151309A0 (en) 2003-04-10
BR122012018280B1 (pt) 2018-01-09
CN1404486A (zh) 2003-03-19
PL362891A1 (en) 2004-11-02
BR122012018280B8 (pt) 2021-05-25
NO328693B1 (no) 2010-04-26
RS50416B (sr) 2009-12-31
UA78676C2 (en) 2007-04-25
US7053054B2 (en) 2006-05-30
CA2399100A1 (en) 2001-08-30
CZ20022856A3 (cs) 2003-01-15
ATE356138T1 (de) 2007-03-15
NO20023963D0 (no) 2002-08-20
EA200200893A1 (ru) 2003-02-27
DK1261622T3 (da) 2007-05-29
CN100480258C (zh) 2009-04-22
PL207728B1 (pl) 2011-01-31
CZ303274B6 (cs) 2012-07-11
US20060079460A1 (en) 2006-04-13
CA2399100C (en) 2011-11-08
BG107001A (bg) 2003-04-30
EE04932B1 (et) 2007-12-17
BR0108553A (pt) 2003-12-23
EP1261622B1 (en) 2007-03-07
JP2003532636A (ja) 2003-11-05
IL151309A (en) 2010-11-30
DE60127100T2 (de) 2007-06-28
BRPI0108553B1 (pt) 2016-06-14
WO2001062774A2 (en) 2001-08-30

Similar Documents

Publication Publication Date Title
EP1571208B1 (en) Novel factor IX purification methods
JP4519646B2 (ja) プレプロインスリンの精製方法
JP3094167B2 (ja) 免疫血清グロブリンの精製方法
CN110526982A (zh) 一种人胰高血糖素样肽-1类似物融合蛋白的纯化方法
UA86938C2 (uk) РЕКОМБІНАНТНИЙ hCG ТА ЙОГО ЗАСТОСУВАННЯ ДЛЯ ВИГОТОВЛЕННЯ ЛІКАРСЬКОГО ЗАСОБУ ДЛЯ ЛІКУВАННЯ РОЗЛАДІВ, ПОВ'ЯЗАНИХ З БЕЗПЛІДНІСТЮ
US5196323A (en) Process for preparing and purifying alpha-interferon
KR19990087623A (ko) 셀룰로스계 여과 보조제를 이용한 혈장 혼합물의 여과
US6001974A (en) Method of separating albumin from serum by ion-exchange chromatography with membrane adsorbers
JP4959898B2 (ja) Lhの精製
RU2054044C1 (ru) Способ получения рекомбинантного человеческого свободного от метионина на n-конце гамма-интерферона
KR101414897B1 (ko) 다베포에틴 알파의 정제 방법
EP0117470B1 (en) Process for producing interferon (ifn-gamma) subtypes 26k and 21k
NO166727B (no) Fremgangsmaate for fremstilling av rekombinant alfa-interferon
WO2021262041A1 (ru) Способ получения высокоочищенного рекомбинантного ингибитора с1-эстеразы человека
RU2223315C2 (ru) РЕКОМБИНАНТНЫЙ АКТИВАТОР α1 ПЛАЗМИНОГЕНА СЛЮНЫ desmondus rotundus (rDSPAα1), СПОСОБ ЕГО ОЧИСТКИ, ФАРМАЦЕВТИЧЕСКАЯ КОМПОЗИЦИЯ НА ЕГО ОСНОВЕ
AU603609B2 (en) Protein purification
KR840001516B1 (ko) 인체 섬유아세포 인터페론의 제조방법
CN103102417B (zh) 一种重组人干扰素α2b-CTP融合蛋白的纯化方法
Kincaid [1] The use of melittin-sepharose chromatography for gram-preparative purification of calmodulin
AU759379B2 (en) Novel factor IX purification methods
US20110230645A1 (en) Purification of factor v
HK1052014B (en) Purified lh
CN116410295A (zh) 一种大肠杆菌表达物的纯化方法
Gu Purification techniques for human growth hormone (hGH) and an hGH antagonist
HK1052016B (en) Process of purification of hcg